BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22870587)

  • 1. Cytokines and cytokine-specific therapy in asthma.
    Desai D; Brightling C
    Adv Clin Chem; 2012; 57():57-97. PubMed ID: 22870587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the interleukin pathway in the treatment of asthma.
    Chung KF
    Lancet; 2015 Sep; 386(9998):1086-96. PubMed ID: 26383000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine and anti-cytokine therapy for asthma.
    Simon HU
    Curr Allergy Asthma Rep; 2006 Mar; 6(2):117-21. PubMed ID: 16566861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine antagonists for the treatment of asthma: progress to date.
    Antoniu SA
    BioDrugs; 2009; 23(4):241-51. PubMed ID: 19697966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-directed therapy in asthma.
    Ichinose M; Barnes PJ
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):263-9. PubMed ID: 15379594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammatory cytokines (IL-4, IL-5 and IL-13)].
    Maeda S; Yanagihara Y
    Nihon Rinsho; 2001 Oct; 59(10):1894-9. PubMed ID: 11676128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2008 Dec; 13(4):643-53. PubMed ID: 19046132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Targeted asthma therapies: confirmations, hopes, and disappointments].
    Schleich F; Louis R
    Rev Med Liege; 2012; 67 Spec No():14-21. PubMed ID: 22690481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursolic acid, a potential PPARĪ³ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
    Kim SH; Hong JH; Lee YC
    Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
    Fajt ML; Wenzel SE
    J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th17-associated cytokines as a therapeutic target for steroid-insensitive asthma.
    Morishima Y; Ano S; Ishii Y; Ohtsuka S; Matsuyama M; Kawaguchi M; Hizawa N
    Clin Dev Immunol; 2013; 2013():609395. PubMed ID: 24454477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the role of cytokines in asthma.
    Renauld JC
    J Clin Pathol; 2001 Aug; 54(8):577-89. PubMed ID: 11477111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting airway inflammation: novel therapies for the treatment of asthma.
    Walsh GM
    Curr Med Chem; 2006; 13(25):3105-11. PubMed ID: 17073650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of JTE013 abrogates experimental asthma by regulating proinflammatory cytokine production from bronchial epithelial cells.
    Terashita T; Kobayashi K; Nagano T; Kawa Y; Tamura D; Nakata K; Yamamoto M; Tachihara M; Kamiryo H; Nishimura Y
    Respir Res; 2016 Nov; 17(1):146. PubMed ID: 27829417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine and anti-cytokine therapy in asthma: ready for the clinic?
    Desai D; Brightling C
    Clin Exp Immunol; 2009 Oct; 158(1):10-9. PubMed ID: 19737225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What goes up must come down: biomarkers and novel biologicals in severe asthma.
    Hilvering B; Pavord ID
    Clin Exp Allergy; 2015 Jul; 45(7):1162-9. PubMed ID: 25640208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic and New Therapies in Asthma.
    Tabatabaian F; Ledford DK; Casale TB
    Immunol Allergy Clin North Am; 2017 May; 37(2):329-343. PubMed ID: 28366480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of histone deacetylase inhibitors in a murine asthma model.
    Ren Y; Su X; Kong L; Li M; Zhao X; Yu N; Kang J
    Inflamm Res; 2016 Dec; 65(12):995-1008. PubMed ID: 27565183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach.
    Zaffini R; Gotte G; Menegazzi M
    Drug Des Devel Ther; 2018; 12():281-293. PubMed ID: 29483769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.